March 20, 2024 — Since its rollout, the Shingrix vaccine has been hailed as a breakthrough in preventing shingles. But its path to widespread adoption has been strewn with obstacles, from pandemic-related disruptions to insurance complexities. The consequences can be seen in vaccine numbers: Only about 30% of adults eligible for Shingrix have gotten it, …
Continue reading “Pandemic and Costs Limited Use of Shingles Vaccine”